Luxturna

Indicated For

RPE65 mutation-associated retinal dystrophy, inherited retinal disease

About This Medication

# Spark Therapeutics Generation Patient Services Patient Guide: How to Get Luxturna (voretigene neparvovec-rzyl) at Low or No Cost Luxturna (voretigene neparvovec-rzyl) is an FDA-approved gene therapy for patients with confirmed biallelic RPE65 gene mutations causing inherited retinal dystrophy, and **Spark Therapeutics Generation Patient Services** offers customized support including co-pay assistance for commercially insured patients and referrals to nonprofits for others[1][3][5]. This guide explains eligibility, application steps, and support options in simple terms to help you access treatment. ## About Luxturna Luxturna is a one-time **ocular gene therapy** delivered via subretinal injection at specialized treatment centers to improve vision in eligible patients with vision loss due to biallelic RPE65 mutations[1][3]. It works by delivering a functional copy of the RPE65 gene to retinal cells, potentially preserving or enhancing remaining vision. Treatment involves two eyes separately, with travel to a designated **ocular gene therapy treatment center** for evaluation and administration. Always discuss with your doctor if Luxturna is right for you, as it's not a cure and results vary[1][7]. ## Who Qualifies for the Program? **Eligibility focuses on medical diagnosis rather than strict income limits.** You qualify if you have confirmed biallelic RPE65 mutations via a CLIA-certified genetic test and have discussed treatment with your healthcare provider[2][3][5][6]. The program is voluntary—participation doesn't affect your ability to get Luxturna—and provides support from diagnosis through post-treatment follow-up[1][7]. It's primarily for **commercially insured patients** needing co-pay help, with referrals to independent nonprofits for government insurance (e.g., Medicare/Medicaid)[program details][4]. ## Income Eligibility Breakdown Income eligibility is **not specified with fixed thresholds**; the program prioritizes insurance type over finances. Commercially insured patients may get co-pay assistance, while others are connected to external resources[program details]. Here's a summary table: | Category | Threshold | Notes | |-------------------|----------------------------|-----------------------------------------------------------------------| | **Individual** | Not specified | Focus on commercial insurance; no FPL limit listed[program details] | | **Couple** | Not specified | Referrals for government insurance to nonprofits[program details] | | **Family of 3** | Not specified | Co-pay help for eligible commercial plans[program details] | | **Family of 4** | Not specified | Income not primary factor; diagnosis is key[program details] | | **FPL Percent** | Not specified | Primarily commercial; nonprofits for others[program details] | Contact the program for personalized assessment, as details may update[1][2]. ## Insurance Requirements The program is **designed for commercially insured patients**, offering benefits investigation, prior authorization support, and co-pay assistance[1][2][9]. If you have **government insurance** like Medicare or Medicaid, you'll be referred to independent nonprofits for help, as Spark does not directly cover these[program details][9]. Provide copies of insurance cards (front/back) during enrollment for verification[2]. The team helps navigate coverage, but approval depends on your plan[9]. ## Step-by-Step Application Process Enrollment is straightforward and can start with you, a caregiver, or your doctor[2][7]. Here's how: 1. **Confirm Diagnosis**: Ensure biallelic RPE65 mutations via CLIA-certified test[2][3]. 2. **Contact Program**: Call **(833) 772-7577** (1-833-SPARK-PS) or email mysparkgeneration@sparktx.com to start[1][2]. 3. **Fill Enrollment Form**: Download the interactive PDF form; include patient info, genetic results, insurance cards, and consents for health info disclosure[2][8]. Referring physicians sign if needed[2]. 4. **Submit Form**: Fax, email, or mail as instructed. Treatment centers use a separate Statement of Medical Necessity[9]. 5. **Team Response**: Expect contact in **1-2 business days** for support team assignment[2][9]. 6. **Benefits Investigation**: Team checks coverage and prior authorization[9]. 7. **Schedule Consultation**: Choose and visit an ocular gene therapy treatment center[1][3]. 8. **Treatment**: After approval, Luxturna ships to the center for administration[program details]. Participation is optional at every step[1][7]. ## Timeline and Delivery **Processing varies by insurance**, but initial contact is 1-2 business days post-enrollment[2][9]. Prior authorization may take weeks; the team provides updates[9]. Delivery is **shipped directly to the treatment center**—no home shipment[program details]. Travel coordination help is available[6]. Post-treatment follow-up support continues[4]. ## Alternatives if Denied or Ineligible If denied commercial coverage, the program refers to **nonprofits** for government insurance or other aid[program details][4]. Explore independent foundations via resources like RxAssist or PAN Foundation. Discuss biosimilars (none currently available) or clinical trials with your doctor[program details]. Uninsured patients may qualify for manufacturer programs through referrals—no direct free drug from Spark noted[program details]. Reapply if circumstances change. ## Important Disclaimer This guide is for informational purposes based on available program details as of latest updates and does not guarantee coverage or assistance. **Consult your healthcare provider and the program directly** for personalized advice, as policies change. Spark provides non-medical support only; medical decisions are yours and your doctor's. Participation is voluntary and won't impact care[1][7]. For full prescribing info, visit luxturna.com. Word count: 1028.

Program information last verified: March 30, 2026